Ichiro Takata
Fukuyama City Hospital · 83 works · 4,257 citations · h-index 14
Top works
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
- Focal Ground-Glass Opacity Detected by Low-Dose Helical CT
- Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007
- Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation
- Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
- Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
- Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
- [Subset analysis of data in the Japanese patients with NSCLC from IDEAL 1 study on gefitinib].
- Hypercalcemia–leukocytosis syndrome associated with lung cancer
- Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy
- Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer
- Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients
- Phase I study of cisplatin, docetaxel and irinotecan for advanced non-small cell lung cancer (NSCLC)
- Primary Lung Cancer Associated with Diffuse Granulomatous Lesions in the Pulmonary Parenchyma.
- A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)
- (−)-Epigallocatechin gallate (EGCG) can prevent cisplatin-induced lung tumorigenesis in A/J mice
- Clinical Usefulness of Serum Cytokeratin 19 Fragment as a Tumor Marker for Lung Cancer.
- Primary Adenoid Cystic Carcinoma of the Trachea Effectively Treated with the Endoscopic Nd-YAG Laser Followed by Radiation.
- Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group